diagnostics

New technology means cancer diagnosis is better than ever.

Advances in genomic testing and other new technologies mean we are spotting cancer earlier, and getting better at identifying the best treatment for patients.

But a greater understanding of the disease – or group of diseases – means a requirement for more tailored treatment plans to improve patient outcomes. This involves challenges for the health service when it comes to capacity, cost, personnel, infrastructure, and expertise. Is the NHS ready?

In this special podcast, sponsored by Daiichi Sankyo, Becky Slack meets Karin Smyth, Labour’s Shadow Health Minister, Professor Clare Turnbull of the Institute for Cancer Research, and Dr. Marc Moodley, Medical Director of Oncology for Daiichi Sankyo. They explore what the new developments in cancer diagnostics and treatment mean for patients and the NHS, and discuss Labour’s plans for the health service.

This New Stateman podcast has been funded by and developed in partnership with Daiichi-Sankyo, a pharmaceutical company specialising in oncology and speciality medicines. For more information visit www.daiichi-sankyo.co.uk

--

To hear all our Spotlight on Policy podcast episodes, visit the standalone feed here: https://podfollow.com/spotlight-on-policy-from-the-new-statesman

Read more from the New Statesman's Spotlight on Policy team here: https://www.newstatesman.com/spotlight

Hosted on Acast. See acast.com/privacy for more information.

This Week in Startups is brought to you by…

Lemon.io - Hire pre-vetted remote developers, get 15% off your first 4 weeks of developer time at https://Lemon.io/twist

OpenPhone. Create business phone numbers for you and your team that work through an app on your smartphone or desktop. TWiST listeners can get an extra 20% off any plan for your first 6 months at openphone.com/twist

LinkedIn Jobs. A business is only as strong as its people, and every hire matters. Go to LinkedIn.com/TWIST to post your first job for free. Terms and conditions apply.

*

Today’s show:

Vital Biosciences CEO Vasu Nadella joins Jason to discuss exactly how Vital’s “VitalOne” conducts 50+ blood tests with a small sample of blood (9:16), building investor trust in the wake of past industry failures (18:45), creating accessible care (40:35), and much more!

*

Time stamps:

(0:00) Vital Biosciences CEO and Co-Founder Vasu Nadella joins Jason

(1:18) Theranos’ background and what prompted Vasu to pursuit

(7:56) Lemon.io - Get 15% off your first 4 weeks of developer time at https://Lemon.io/twist

(9:16) Vasu demos how the VitalOne works, lessons learned on Vital’s journey

(18:45) Scaling the company, raising a war chest, building trust in the product, benchmarking and governance for labs

(27:36) OpenPhone - Get 20% off your first six months at https://openphone.com/twist

(29:07) State of lab robotics, paths for incorporating AI into Vital’s technology, benefits of converging technologies

(39:16) LinkedIn Jobs - Post your first job for free at https://linkedin.com/twist

(40:35) Creating accessible modern lab testing

(45:38) Consumer behavior and the outcome of consumers controlling spend

*

Check out Vital Bio: https://vitalbio.com

FOLLOW Vasu: https://twitter.com/vasunadella

*

Read LAUNCH Fund 4 Deal Memo: https://www.launch.co/four

Apply for Funding: https://www.launch.co/apply

Buy ANGEL: https://www.angelthebook.com

Great recent interviews: Steve Huffman, Brian Chesky, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarland, PrayingForExits, Jenny Lefcourt

Check out Jason’s suite of newsletters: https://substack.com/@calacanis

*

Follow Jason:

Twitter: https://twitter.com/jason

Instagram: https://www.instagram.com/jason

LinkedIn: https://www.linkedin.com/in/jasoncalacanis

*

Follow TWiST:

Substack: https://twistartups.substack.com

Twitter: https://twitter.com/TWiStartups

YouTube: https://www.youtube.com/thisweekin

*

Subscribe to the Founder University Podcast: https://www.founder.university/podcast